SNAL vs WST · rev $81.2M vs P/E 35, rev $1.72B
Snail, Inc. Class A Common Stock (SNAL) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
Snail, Inc. Class A Common Stock (SNAL) is a electronic gaming & multimedia company listed on NASDAQ.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported SNAL revenue for 2025-12-31 was $81.2M. Net income was -$27.2M. Revenue was down 3.8% from 2024-12-31 to 2025-12-31. SNAL currently screens at market cap $27.0M.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
SNAL currently screens at market cap $27.0M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the SNAL and WST stock pages for the full models.
Not investment advice.